...
首页> 外文期刊>Bone marrow transplantation >Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period.
【24h】

Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period.

机译:HBsAg阴性,HBsAb阳性接受者骨髓移植后的暴发性乙型肝炎;在免疫抑制期重新激活休眠病毒。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

It is widely accepted that seroconversion of HBsAg to HBsAb indicates clearance of hepatitis B virus. We describe a 50-year-old man with chronic myelocytic leukemia who developed lethal hepatitis B 22 months after allo-BMT. He had been negative for HBsAg and positive for HBsAb before BMT. Hepatitis B virus latently existing in the liver cells before BMT proliferated during the immunosuppressed period causing fatal hepatitis. Recipients with positive HBsAb should be considered to have the potential for active hepatitis B to emerge after BMT. Bone Marrow Transplantation (2000) 25, 105-108.
机译:HBsAg血清转化为HBsAb被认为可以清除乙型肝炎病毒,这一点已被广泛接受。我们描述了一个50岁的慢性粒细胞性白血病,在同种BMT后22个月发展为致命性乙型肝炎。在BMT前,他的HBsAg阴性和HBsAb阳性。在免疫抑制期BMT增生之前,肝细胞中潜伏存在的乙型肝炎病毒会导致致命的肝炎。 HBsAb阳性的接受者应被认为在BMT后可能出现活动性乙型肝炎。骨髓移植(2000)25,105-108。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号